Fluid Biotech Revenue and Competitors

Calgary, AB CAN

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Fluid Biotech's estimated annual revenue is currently $4.3M per year.(i)
  • Fluid Biotech's estimated revenue per employee is $155,000

Employee Data

  • Fluid Biotech has 28 Employees.(i)
  • Fluid Biotech grew their employee count by 27% last year.

Fluid Biotech's People

NameTitleEmail/Phone
1
VP OperationsReveal Email/Phone
2
VP, Business DevelopmentReveal Email/Phone
3
Senior Quality EngineerReveal Email/Phone
4
Quality CoordinatorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M1110%N/AN/A
#2
$4.3M568%$1.7MN/A
#3
$3M3915%N/AN/A
#4
$4.2M54-4%N/AN/A
#5
$14.4M9341%N/AN/A
#6
$4.5M2926%N/AN/A
#7
$0.9M12-8%N/AN/A
#8
$3.7M24-17%N/AN/A
#9
$8.7M56-8%$100KN/A
#10
$3.3M2162%$13.4MN/A
Add Company

What Is Fluid Biotech?

Fluid Biotech is a start-up located in Calgary, Alberta. The company is developing an innovative brain stent to heal aneurysms. It represents years of research work from the laboratories at the University of Calgary.

keywords:N/A

N/A

Total Funding

28

Number of Employees

$4.3M

Revenue (est)

27%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Fluid Biotech News

2022-04-19 - Global Tumor Fluid Biopsy Market 2022 Emerging Trend and ...

Cellmax Life; Burning Rock Biotech; Berry Genomics Co; HaploX Biotechnology Co; New Horizon Health Limited; Genetronhealth; Amoy Diagnostics Co...

2022-04-19 - Instant Oral Fluid Testing Devices Market Size 2022-2029 ...

Instant Oral Fluid Testing Devices Market Size 2022-2029| Key Players – Abbott Laboratories, AccuBioTech, Guangzhou Wondfo Biotech, MEDACX Ltd.

2022-04-17 - Bayer nabs yet another oncology leader from GSK to bolster ...

Insight CXR Triage analyzes scans for presuspected conditions, such as a critical build-up of fluid or a collapsed lung. It then alerts clinicians of urgent...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.8M2827%N/A
#2
$2.8M28N/AN/A
#3
$4.3M2817%N/A
#4
$4.8M2817%N/A
#5
$2.9M29N/AN/A